Marksans Pharma to acquire 100% of German pharma distributor ABCnow GmbH

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

MARKSANS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹261.80

prior close

₹265.75

announcement price

In-mkt

timing

Nifty Microcap 250market-2.0%+2.8% vs market

Pharmaceuticals peers, median of 165sector-0.8%+1.6% vs sector

On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+1.0

15m

+1.1

30m

+1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8-2.0+2.8-0.8+1.6

Next day

+6.5-0.1+6.6+0.0+6.5

+3.8+1.2+2.6+0.5+3.3

+3.1+1.4+1.7+1.0+2.1

+3.5+0.4+3.2+0.2+3.3

+5.5+1.0+4.5+0.8+4.6

+1.8-0.5+2.3-0.4+2.2

15d

-0.9-0.6-0.4-0.3-0.6

+3.7+3.4+0.3-0.3+4.0

+28.0+6.0+21.9+3.1+24.9

+17.6+1.1+16.6-1.7+19.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Marksans Pharma signed a deal to acquire 100% of ABCnow GmbH, a German OTC pharma distributor based in Flensburg, for about 892,384 euros in cash. ABCnow had revenue of 227,233 euros in 2025 and 510,215 euros in 2024. The deal gives Marksans its own front-end sales access in Germany to sell products made in India, UK and USA. No regulatory approvals needed and it is not a related-party deal. Closing is expected by 31 July 2026.

Likely market impact

Small ticket size but strategically important, giving Marksans direct entry into the German and broader European OTC market.